Viva Biotech Holdings (HKG:1873)

Viva Biotech Holdings Revenue

Viva Biotech Holdings had revenue of 1.01B CNY in the half year ending June 30, 2026, with 2.52% growth. This brings the company's total for the last twelve months to 1.90B, up 3.67% year-over-year. In the year 2025, Viva Biotech Holdings had annual revenue of 1.73B, down -12.95%. That makes Viva Biotech Holdings the 14,983rd largest company in the world by revenue and 884th in Hong Kong.

• Revenue (ttm): 1.90B CNY
• Revenue Growth: +3.67%
• P/S Ratio: 1.28
• Revenue / Employee: 860.41K CNY
• Employees: 2,213
• Market Cap: 2.71B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Segment

By Segment

Chart

• Contract Development Manufacture Organisation (CDMO) and Commercialisation Services 894.11M 50.9%
• Drug Discovery Services 854.72M 48.6%
• Viva Bioinnovator 9.31M 0.5%

By Geography

Chart

• United States of America (USA) 830.80M 48.0%
• Europe 461.28M 26.7%
• Chinese Mainland 259.65M 15.0%
• Other Asia countries and regions out of Chinese Mainland 92.27M 5.3%
• Others 67.63M 3.9%
• Africa 17.82M 1.0%

Fiscal year ended Dec 31, 2025 See the full Viva Biotech Holdings breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.73B	-257.21M	-12.95%
Dec 31, 2024	1.99B	-168.93M	-7.84%
Dec 31, 2023	2.16B	-224.05M	-9.42%
Dec 31, 2022	2.38B	275.55M	13.10%
Dec 31, 2021	2.10B	1.41B	201.90%

Data Source: S&P Global Market Intelligence Last updated: Sep 22, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 21, 2026

Data Sources Report a data error